All In MedTech

FDA Clearance Tracker · P150038-S022

Exablate 4000 System Type-1 (i.e. Type 1.0/1.1)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 8, 2022 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 8, 2022

Approved

Time to decision

177 days

Received Jun 14, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P150038-S022
Device name
Exablate 4000 System Type-1 (i.e. Type 1.0/1.1)
Applicant
Insightec
Applicant location
Tirat Carmel
Received
Jun 14, 2022
Decided
Dec 8, 2022
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P150038

Device type

Device class
Class III

Every decision under product code POH

FDA's approval statement

As written in FDA's record.

Approval for labeling changes to the indications for use of the device in idiopathic Essential tremor patients with medication-refractory tremor.

Source documents

Other decisions for Insightec

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.